ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

NCI Decides To Accept NCAB Recommendation, Award Organ Systems Coordinating Center to Roswell Park

July 6, 1984

White House Group Calls For Improved Action Against Carcinogens

September 28, 1979

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004